Wegovy: What It Is, Who It Helps, and What to Expect
Wegovy (semaglutide) is an FDA-approved once-weekly GLP-1 injection indicated for chronic weight management in adults with obesity or overweight with […]
obesity medicine
Uncategorized
Side Effect of Ozempic: What to Know and When to Act
If you're starting Ozempic, or you've already noticed stomach symptoms after a dose, the side effect of Ozempic is usually
Calorie Deficit Formula: Step-by-Step Calculation Guide
A calorie deficit formula is estimated maintenance calories, or TDEE, minus a planned daily reduction, commonly 500 to 750 kcal
Tirzepatide Side Effects: A Patient’s Guide to Safety
Tirzepatide's most common side effects are gastrointestinal: nausea affects 25% at 5 mg, 29% at 10 mg, and 28% at
GLP 1 Medications: A Complete Patient Guide
Could a medication that helps with appetite and blood sugar also require a long-term plan for nutrition, side effects, and
Calorie Deficit: What It Is and How to Use It Safely
A calorie deficit means eating fewer calories than your body uses, and clinical weight-loss programs often begin with a 500–750
Obesity Explained: Causes, Risks, and Evidence-Based Care
Obesity is a chronic, multifactorial disease involving excess body fat that impairs health, not a failure of willpower. In 2022,
Semaglutide for Weight Management: What Patients Should Know
Semaglutide is a GLP-1 receptor agonist available as Wegovy for chronic weight management and Ozempic for type 2 diabetes, and
GLP-1 Medicines Explained: How They Work and What to Expect
Could the most important GLP-1 question be what happens after the medication stops, rather than how quickly weight comes off?
Mounjaro Explained What Tirzepatide Does and Who It Helps
Mounjaro is tirzepatide, and the FDA approves it to improve glycemic control in adults with type 2 diabetes as an